148 related articles for article (PubMed ID: 2473359)
41. Interleukin-4 as a growth regulator of clonogenic cells in acute myelogenous leukemia in suspension culture.
Miyauchi J; Clark SC; Tsunematsu Y; Shimizu K; Park JW; Ogawa T; Toyama K
Leukemia; 1991 Feb; 5(2):108-15. PubMed ID: 1708433
[TBL] [Abstract][Full Text] [Related]
42. Interactions between retinoic acid and colony-stimulating factors affecting the blast cells of acute myeloblastic leukemia.
Tohda S; Minden MD; McCulloch EA
Leukemia; 1991 Nov; 5(11):951-7. PubMed ID: 1961035
[TBL] [Abstract][Full Text] [Related]
43. Heterogeneity in acute myeloblastic leukemia.
McCulloch EA; Kelleher CA; Miyauchi J; Wang C; Cheng GY; Minden MD; Curtis JE
Leukemia; 1988 Dec; 2(12 Suppl):38S-49S. PubMed ID: 3199879
[TBL] [Abstract][Full Text] [Related]
44. [Proliferation and differentiation of leukemic cells in acute myelocytic leukemia].
Nara N
Rinsho Byori; 1998 May; 46(5):424-9. PubMed ID: 9627492
[TBL] [Abstract][Full Text] [Related]
45. Transforming growth factor beta inhibits the proliferation of the blast cells of acute myeloblastic leukemia.
Tessier N; Hoang T
Blood; 1988 Jul; 72(1):159-64. PubMed ID: 3291977
[TBL] [Abstract][Full Text] [Related]
46. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
Kamijo R; Takeda K; Nagumo M; Konno K
J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994
[TBL] [Abstract][Full Text] [Related]
47. Mechanism of action of interleukin 1 on the progenitors of blast cells in acute myeloblastic leukemia.
Murohashi I; Tohda S; Suzuki T; Nagata K; Yamashita Y; Nara N
Exp Hematol; 1990 Feb; 18(2):133-7. PubMed ID: 2406155
[TBL] [Abstract][Full Text] [Related]
48. Sensitivity of hematopoietic progenitors of acute myeloblastic leukemia to new compounds derived from marine organisms.
Lishner M; Shur I; Bleiberg I; Rudi A; Kashman Y; Fabian I
Leukemia; 1995 Sep; 9(9):1543-8. PubMed ID: 7658723
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of the blast self-renewal capacity in patients with acute myeloid leukemia.
Nara N; Kurokawa H; Tanikawa S; Tomiyama J; Nagata K
Cancer; 1994 Jan; 73(1):92-7. PubMed ID: 8275443
[TBL] [Abstract][Full Text] [Related]
50. Effects of recombinant G-CSF and GM-CSF on the growth in methylcellulose and suspension of the blast cells in acute myeloblastic leukemia.
Murohashi I; Nagata K; Suzuki T; Maruyama Y; Nara N
Leuk Res; 1988; 12(5):433-40. PubMed ID: 3260000
[TBL] [Abstract][Full Text] [Related]
51. The blast cells of acute myeloblastic leukaemia.
McCulloch EA
Clin Haematol; 1984 Jun; 13(2):503-15. PubMed ID: 6380855
[TBL] [Abstract][Full Text] [Related]
52. Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells.
Kerangueven F; Sempere C; Tabilio A; Mannoni P
Eur Cytokine Netw; 1990; 1(2):99-107. PubMed ID: 2129395
[TBL] [Abstract][Full Text] [Related]
53. Comparison of the proliferative activity and sensitivity to cytosine arabinoside of leukemic blast progenitors in acute myeloblastic leukemia at diagnosis and in relapse.
Nara N; Tohda S; Suzuki T; Nagata K; Tanikawa S; Imai Y; Tomiyama J; Shiina S
Acta Haematol; 1992; 88(1):17-21. PubMed ID: 1414157
[TBL] [Abstract][Full Text] [Related]
54. Effects of rGM-CSF and rG-CSF on the cisplatin sensitivity of the blast cells of acute myeloblastic leukemia.
Wang YF; Kelleher CA; Minkin S; McCulloch EA
Leukemia; 1991 Mar; 5(3):239-48. PubMed ID: 1707468
[TBL] [Abstract][Full Text] [Related]
55. Relationship between the in vitro sensitivity to cytosine arabinoside of blast progenitors and the outcome of treatment in acute myeloblastic leukaemia patients.
Nara N; Suzuki T; Nagata K; Yamashita Y; Murohashi I; Adachi Y
Br J Haematol; 1988 Oct; 70(2):187-91. PubMed ID: 3191030
[TBL] [Abstract][Full Text] [Related]
56. Mixed colony formation composed of erythroblasts and myeloblasts by leukemic blast progenitors in patients with erythroleukemia.
Nara N; Tanikawa S; Shiina S
Exp Hematol; 1993 Jan; 21(1):98-102. PubMed ID: 8417964
[TBL] [Abstract][Full Text] [Related]
57. Recombinant murine granulocyte-macrophage (GM) colony-stimulating factor supports formation of GM and multipotential blast cell colonies in culture: comparison with the effects of interleukin-3.
Koike K; Ogawa M; Ihle JN; Miyake T; Shimizu T; Miyajima A; Yokota T; Arai K
J Cell Physiol; 1987 Jun; 131(3):458-64. PubMed ID: 3298286
[TBL] [Abstract][Full Text] [Related]
58. Response of the blast stem cells of acute myeloblastic leukemia to G-CSF, GM-CSF, or the ligand for C-KIT, alone or in combination.
McCulloch EA; Minkin S; Curtis JE; Minden MD
Hematopathol Mol Hematol; 1996; 10(3):111-22. PubMed ID: 8878730
[TBL] [Abstract][Full Text] [Related]
59. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells.
Grant S; Traylor R; Bhalla K; McCrady C; Pettit GR
Leukemia; 1992 May; 6(5):432-9. PubMed ID: 1593908
[TBL] [Abstract][Full Text] [Related]
60. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
